Corey Hebert
MD
Dr. Corey Hebert is an Associate Professor at both LSU Health Sciences Center and Tulane University Medical Center in New Orleans, Louisiana and has been the Principal Investigator on over 70 phase 1, 2 and 3 FDA regulated clinical trials on various nutritional and pharmacotherapeutic agents.
Dr. Hebert is a highly regarded medical broadcast journalist, working as on-air Chief Medical Correspondent for the CBS television affiliate in New Orleans, Louisiana and the Gulf Coast for over 19 years. He is a frequent on-air contributor to the Discovery Channel and the Dr. Oz Show and he has made hundreds of appearances on national television networks and outlets such as CNN, CBS, National Geographic, Good Morning America and the Today Show.
Dr. Hebert served as the Chairman of the Executive Advisory Council of the National Health Service Corps and was previously on the CDC board on Influenza. He has been the author on peer reviewed journal publications in the New England Journal of Medicine and the Journal of Human Vaccines and Immunotherapeutics and he is currently the principal investigator on multiple Covid-19 vaccine and monoclonal antibody trials.
He is also the Chief Medical Officer of Dillard University and Chief Medical Officer of Emmaus Life Sciences.
Dr. Hebert is a highly regarded medical broadcast journalist, working as on-air Chief Medical Correspondent for the CBS television affiliate in New Orleans, Louisiana and the Gulf Coast for over 19 years. He is a frequent on-air contributor to the Discovery Channel and the Dr. Oz Show and he has made hundreds of appearances on national television networks and outlets such as CNN, CBS, National Geographic, Good Morning America and the Today Show.
Dr. Hebert served as the Chairman of the Executive Advisory Council of the National Health Service Corps and was previously on the CDC board on Influenza. He has been the author on peer reviewed journal publications in the New England Journal of Medicine and the Journal of Human Vaccines and Immunotherapeutics and he is currently the principal investigator on multiple Covid-19 vaccine and monoclonal antibody trials.
He is also the Chief Medical Officer of Dillard University and Chief Medical Officer of Emmaus Life Sciences.
